Effect of Bifidobacterium bifidum supplementation on growth and development of term infants at 1 year of age

Effect of Bifidobacterium bifidum supplementation on growth and development of term infants at 1 year of age - Effect of Bifidobacterium on growth and development of term infants

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029087

Enrollment

100

Registered

2017-09-11

Start date

2017-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Term infants

Interventions

Bifidobacterium bifidum OLB6378 powder (Meiji Co., Ltd., Tokyo, Japan) (0.5g/package) is administered twice a day, and continued until 1 month after birth No administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Term infants

Exclusion criteria

Exclusion criteria: Infants with complications

Design outcomes

Primary

Measure	Time frame
Morbidities during the first year of life	—

Secondary

Measure	Time frame
Growth and development at 1 year of age	—

Countries

Japan

Contacts

Public ContactSatoshi Kusuda

kyorindai university Headquaters

kusuda-satoshi@umin.ac.jp0338350435

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026